University Hospital Maastricht
Maastricht, Limburg, 6229 HX, Netherlands
NCT Number: NCT01175317
58 patients undergoing surgery of the large bowel are divided into two groups. The control group will receive standard care. The intervention group will receive standard care plus optimization of the blood circulation based on in- or decrease of the output of the heart. Between group differences are measured primarily by markers of intestinal damage in plasma and urine. Also CO2 pressure in the stomach lumen is measured (reflecting blood supply to the gut).
The investigators hypothesize that the intervention group will have less intestinal damage, improved blood supply to the bowel and improved recovery of the operation compared to the control group.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Maastricht, Limburg, 6229 HX, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fluid administration and optimization based on cardiac output findings during surgery and during the first 8 hours of the postoperative phase.
Fluid regimen based on expertise anaesthesist
Time frame: 1 hour postoperatively
Intestinal-Fatty Acid Binding Protein (a marker of intestinal damage) is measured in plasma.
The primary outcome measure is the difference in peak values of I-FABP between the control group and the intervention group.
Time frame: Average intraoperative CO2 gap
The CO2 gap (difference arterial pCO2 and pCO2 of the stomach lumen) reflects global intestinal perfusion status and is measured every 15 minutes intraoperatively and every 60 minutes during the first 8 hours postoperatively.
Intraoperative measurements were averaged per individual patient, producing the average intraoperative CO2 gap.
Maastricht University Medical Center
Other
Does Hemodynamic Optimization During and After Colorectal Surgery Result in Improved Intestinal Perfusion, Sustained Intestinal Barrier and Improved Postoperative Recovery?
Acronym: HOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02009449
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT03086096
Colonic Diseases, Colorectal Carcinoma
Vienna, State of Vienna, Austria
View Trial DetailsNCT04868773
CRC, Colonic Diseases
Orange, California, United States
View Trial DetailsNCT04081779
Breast Carcinoma, Breast Diseases
Seattle, Washington, United States
View Trial Details